Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.

Controlled trials over two decades ago showed that the polysaccharide vaccine prevented meningococcal meningitis. Subsequent observational studies suggested variations in the level and duration of protection, particularly among young children.